John Konsin Email & Phone Number

Portland, Me, Us

Biddeford, Me, Us

Prapela is developing the first non-invasive stimulation therapy to improve breathing rhythm and lung function in newborns. Our first product is a hospital bassinet pad shown to reduce the amount and days of morphine treatment in newborns exposed to opioids before birth. Our second product is a hospital incubator pad that reduces apneic events in preterm newborns. Apnea of prematurity or AOP occurs when newborns stop breathing for twenty seconds or more. The only FDA-approved treatment for AOP, caffeine is only partially effective. Used with caffeine treatment, we expect to reduce the number of apneas experienced by the tiniest of humans. The latest project is a hospital incubator pad to minimize persistent hypoxemia (low blood oxygen) in early preterm newborns. A recent study reported that intermittent hypoxemia is associated with several poor outcomes, including the need for respiratory medications, bronchopulmonary dysplasia, and death. The company has won $8.14M in non-dilutive funding awards from the Ohio Third Frontier, Johnson & Johnson, the FDA-sponsored Pediatric Device Consortium (3X winner), Massachusetts Life Science Center, Maine Technology Institute, and SBIR grants from the National Institutes of Health. On May 20, 2021, we received a $2.5M Phase II SBIR grant funded by the National Institute on Drug Abuse (NIDA) supporting a new clinical study with Tufts Medical Center for opioid-exposed babies. On March 10, 2023, we were awarded another $3.5M SBIR grant to improve the treatment of AOP. In addition, we're incredibly grateful to the Charles H. Hood Foundation and the State of Ohio for their much-needed support in 2018-2019.

Boston, Ma, Us

In alliance with Harvard's Schools of Medicine, Engineering, and Arts & Sciences, researchers at the Wyss Institute are developing new innovative solutions for healthcare. I developed the first commercialization and business plan for a breakthrough microbiome application. By early 2017, I started my work to spinout SVS technology and create Prapela, Inc.

Vancouver, Wa, Us

RS Medical is focused on DME products with a focus on exceeding the expectations of the Veterans Health Administration. RS Medical products provide drug free pain relief to thousands of Veterans suffering from lumbago and knee pain.

Vancouver, Wa, Us

RS Medical is focused on DME products supporting Pain Medicine Physicians. The company's RS-4i(r) Plus product has been well accepted by physicians across many different medical specialties and leading insurance organizations as well as the US Department of Veterans Affairs. I led the company and brought in new management, processes, systems and product innovations through strategic partnerships.

Vancouver, Washington, Us

Molecular Testing Laboratories is leader in Pharmacogenomic testing with additional services in Toxicology, Infectious Disease and genetic diet and exercise testing. As Senior Advisor, I led an initiative focused on partnerships in biotech and pharma and a new product launch.

Minneapolis, Mn, Us

Covidien, before being acquired by Medtronic, was a leading medical device company focused on surgical innovations. I led an initiative in Sports Medicine and later assisted on projects within the Surgical Devices GBU.

Previous to being acquired by Greatbatch and then Integer, I led Accellent's Endsocopy business unit and initiated lean manufacturing initiatives across 10 manufacturing locations serving Johnson & Johnson, Medtronic, Boston Scientific and Smith & Nephew.

Watford, Hertfordshire, Gb

Smith & Nephew Endoscopy is primarily focused on the Orthopedic Sports Surgery market and holds a significant global market share in several product segments including; ACL repair, Meniscal repair, Rotator Cuff repair, Tissue Resection, Visualization and arthroscopic access. I led the global marketing function and was later promoted to General Manager over the Ob/Gyn and Vascular business units.

Emeryville, California, Us

Chiron's diagnostic business included Immunoassay, Blood Gas and bDNA specialty diagnostics sold Worldwide. Chiron acquired the business from Ciba Corning and later sold the business to Bayer Diagnostics who then sold the business to Seimens. I led marketing for the US business and then led the global launch of the ACS:Centaur System - at the time the fastest immunoassay system in the World.

Amsterdam, Noord-Holland, Nl

Advanced Technology Laboratories, was previously part of Westmark, Inc. then an independent company and was later acquired by Philips Medical. With others, I developed the company's first 5-year strategic marketing plan and product roadmap.

Irving, Tx, Us

St Paul, Mn, Us

Executive Education Program, Global Business

Mba

Bachelor Of Science (B.S.), Business Administration, Marketing

Executive Education, Leadership Excellence Program